France's Sanofi to buy biotech firm Synthorx for $2.5 billion

·

·

France's Sanofi to buy biotech firm Synthorx for $2.5 billion

PARIS (Reuters) – Sanofi (SASY.PA) said on Monday it had agreed to buy California-headquartered biotechnology firm Synthorx in a cash deal worth about $2.5 billion (1.95 billion pounds) aimed at beefing up the French drugmaker’s pipeline of drugs for …
See Original Article

Osram shares surge after AMS declares victory in takeover bid

VIENNA (Reuters) – Shares in Osram (OSRn.DE) surged on Monday after Austrian sensor maker AMS (AMS.S) said it had succeeded at its second attempt with a 4.6 billion euro ($5.1 billion) takeover bid for the German lighting group. Osram’s shares overshot …
See Original Article

European shares dip after weak China data; Tullow slumps

By Medha Singh and Lisa Pauline Mattackal. Dec 9 (Reuters) – European stocks slipped on Monday, dragged down by a slump in shares of Tullow Oil Plc after the oil and gas explorer scrapped its dividend, while weak data out of China also weighed on …
See Original Article

A wee dram likely to cost a pretty penny at whisky auction

London — There are whisky collectors — and then there was Richard Gooding. For two decades, the Colorado businessman and philanthropist spent countless hours exploring distilleries in Scotland and trolling auctions in his quest for the finest scotch …
See Original Article

Gold inches up on US-China trade uncertainty; Fed meet in focus

(Reuters) – Gold inched up on Monday as investors awaited cues from the U.S. Federal Reserve on its monetary policy outlook, while trying to size up the chances of a new round of U.S. tariffs on Chinese goods. FILE PHOTO: Liquid gold is poured to form gold …
See Original Article



Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.